IRF3 and infection: Moreover, the use of the mTOR inhibitor Ku-0063794 or the mTORC1 inhibitor rapamycin did not affect the ability of IRF3 to accumulate into the nuclear compartment following the infection of primary fibroblasts with SeV (Fig 9C and S7A Fig).